APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,863,606 | -47.3% | 11,766,000 | 0.0% | 0.17% | -50.1% |
| Q2 2023 | $28,207,024 | +24.4% | 11,766,000 | -3.4% | 0.34% | +25.0% |
| Q1 2023 | $22,669,901 | +21.2% | 12,175,000 | 0.0% | 0.27% | +38.1% |
| Q4 2022 | $18,702,513 | +15.0% | 12,175,000 | +46.2% | 0.19% | +10.9% |
| Q3 2022 | $16,256,000 | -75.0% | 8,325,000 | -81.0% | 0.18% | -73.1% |
| Q2 2022 | $65,016,000 | -33.0% | 43,874,000 | -28.5% | 0.65% | -31.3% |
| Q1 2022 | $97,046,000 | +36.9% | 61,374,000 | +30.9% | 0.95% | +43.5% |
| Q4 2021 | $70,903,000 | +69.3% | 46,874,000 | +37.9% | 0.66% | +82.8% |
| Q3 2021 | $41,869,000 | -47.5% | 33,996,000 | -20.7% | 0.36% | -40.5% |
| Q2 2021 | $79,763,000 | +1796.4% | 42,855,000 | +1328.5% | 0.61% | +1586.1% |
| Q1 2021 | $4,206,000 | -80.0% | 3,000,000 | -76.0% | 0.04% | -76.6% |
| Q4 2020 | $20,991,000 | +54.4% | 12,502,000 | 0.0% | 0.15% | +27.3% |
| Q3 2020 | $13,594,000 | – | 12,502,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 54,825,000 | $92,483,000 | 1.83% |
| Opti Capital Management, LP | 5,000,000 | $8,414,000 | 0.94% |
| Castle Creek Arbitrage, LLC | 8,984,000 | $15,089,000 | 0.92% |
| CSS LLC/IL | 5,919,000 | $9,944,000 | 0.38% |
| LMR Partners LLP | 8,640,000 | $14,556,000 | 0.23% |
| MACKAY SHIELDS LLC | 18,878,000 | $31,802,000 | 0.22% |
| Shaolin Capital Management LLC | 1,693,000 | $2,857,000 | 0.20% |
| SSI INVESTMENT MANAGEMENT LLC | 1,500,000 | $2,516,000 | 0.18% |
| WOLVERINE ASSET MANAGEMENT LLC | 12,502,000 | $20,991,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,370,000 | $3,983,000 | 0.10% |